Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies - PubMed
3 hours ago
- #CAR T-cell therapy
- #cutaneous adverse events
- #hematologic malignancies
- Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies
- No competing interests declared by the authors
- Reference to ABECMA (idecabtagene vicleucel) package insert by Bristol-Myers Squibb Company